Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer (GAST-TaxXel)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by University of Turku.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Sanofi
Information provided by:
University of Turku
ClinicalTrials.gov Identifier:
NCT00669370
First received: April 28, 2008
Last updated: April 29, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)